Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?
- PMID: 21716667
- PMCID: PMC3118295
- DOI: 10.4061/2011/943216
Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?
Abstract
One of the most important and complex diseases of modern society is metabolic syndrome. This syndrome has not been completely understood, and therefore an effective treatment is not available yet. We propose a possible stem cell mechanism involved in the development of metabolic syndrome. This way of thinking lets us consider also other significant pathologies that could have similar etiopathogenic pathways, like lipodystrophic syndromes, progeria, and aging. All these clinical situations could be the consequence of a progressive and persistent stem cell exhaustion syndrome (SCES). The main outcome of this SCES would be an irreversible loss of the effective regenerative mesenchymal stem cells (MSCs) pools. In this way, the normal repairing capacities of the organism could become inefficient. Our point of view could open the possibility for a new strategy of treatment in metabolic syndrome, lipodystrophic syndromes, progeria, and even aging: stem cell therapies.
Figures
References
-
- Saito I, Iso H, Kokubo Y, Inoue M, Tsugane S. Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study. Circulation Journal. 2009;73(5):878–884. - PubMed
-
- Zimmet P, Alberti G. The metabolic syndrome: progress towards one definition for an epidemic of our time. Nature Clinical Practice Endocrinology and Metabolism. 2008;4(5):p. 239. - PubMed
-
- Reaven GM. The metabolic syndrome: requiescat in Pace. Clinical Chemistry. 2005;51(6):931–938. - PubMed
-
- Pappolla MA, Bryant-Thomas TK, Herbert D, et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology. 2003;61(2):199–205. - PubMed
-
- Junyent M, Gilabert R, Jarauta E, et al. Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia. Atherosclerosis. 2010;208(2):437–441. - PubMed
LinkOut - more resources
Full Text Sources